These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28339091)
21. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
22. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1. Zhang Y; Wang F; Wang L; Zhang Q World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945 [TBL] [Abstract][Full Text] [Related]
23. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
24. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway. Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526 [TBL] [Abstract][Full Text] [Related]
25. FBLN3 inhibited the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway. Mao HY; Liu SP; Kong GM; Xu Y; Xu YC; Sun GZ; Wang Z; Han F; Tong JD; Bo P Neoplasma; 2019 May; 66(3):336-342. PubMed ID: 30784281 [TBL] [Abstract][Full Text] [Related]
26. TGF-β is associated with poor prognosis and promotes osteosarcoma progression Ma K; Zhang C; Li W Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027 [TBL] [Abstract][Full Text] [Related]
27. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway. Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480 [TBL] [Abstract][Full Text] [Related]
28. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma. Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581 [TBL] [Abstract][Full Text] [Related]
29. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
30. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
31. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer. Zhang X; Liu S; Zhu Y Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379 [TBL] [Abstract][Full Text] [Related]
32. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
33. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway. Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698 [TBL] [Abstract][Full Text] [Related]
34. Ginsenoside CK induces apoptosis and suppresses proliferation and invasion of human osteosarcoma cells through the PI3K/mTOR/p70S6K1 pathway. Chen K; Jiao J; Xue J; Chen T; Hou Y; Jiang Y; Qian L; Wang Y; Ma Z; Liang Z; Sun B; Ren Q Oncol Rep; 2020 Mar; 43(3):886-896. PubMed ID: 32020217 [TBL] [Abstract][Full Text] [Related]
35. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway. Wang S; Zhao G; Zhao S; Qiao Y; Yang H Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946 [TBL] [Abstract][Full Text] [Related]
36. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma. Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903 [TBL] [Abstract][Full Text] [Related]
37. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918 [TBL] [Abstract][Full Text] [Related]
38. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
39. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer. Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212 [TBL] [Abstract][Full Text] [Related]
40. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]